Notable earnings before Thursday's open

09:30pm, Wednesday, 29'th Apr 2020
AAL, ABMD, AGIO, AIMC, AIT, AMRN, ARW, ASPS, AUY, BAX, BC, BEN, BPOP, CFR, CG, CHD, CI, CMCSA, COLB, COP, COR, CRS, CWT, DAN, DNKN, DOW, EME, ESI, ETN, FBP, FCN, FLWS, GNRC, GRA, GT, HBI, HGV, HUBB, I

IDEXX Laboratories Q1 2020 Earnings Preview

09:30pm, Wednesday, 29'th Apr 2020
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q1 earnings results on Thursday, April 30th, before market open.The consensus EPS Estimate is $1.20 (+2.6% Y/Y) and the consensus Revenue Esti
The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
BBVA USA Bancshares Inc. lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 4.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissi
Here’s how to take care of pets during the COVID-19 pandemic
Clarius Group LLC raised its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 8.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Co
IDEXX Laboratories, Inc. (NASDAQ:IDXX) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,070,000 shares, a growt
Hartford Investment Management Co. grew its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange
Cribstone Capital Management LLC decreased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.5% in the first quarter, according to the company in its most recent 13F filing with the SEC. The
Equities research analysts expect IDEXX Laboratories, Inc. (NASDAQ:IDXX) to post sales of $631.77 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for IDEX
Cabot Wealth Management Inc. trimmed its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 1.6% during the first quarter, Holdings Channel reports. The firm owned 4,037 shares of the company’s s
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE